Table 1.
Composition | Type of Silk | Application | Evaluation Stage | Reference |
---|---|---|---|---|
SF SF |
Silk fibroin | Tissue engineering | In vitro | [66] |
Silk fibroin | Liver tissue engineering | In vitro | [22] | |
SF | Silk fibroin | Tissue engineering | In vitro | [67] |
SF | Silk fibroin | Drug delivery | In vitro | [68] |
SF | Silk fibroin | Drug delivery/Tissue engineering | In vivo | [69] |
SF | Silk fibroin | Regeneration of annulus fibrosus/ Drug delivery |
In vivo | [70] |
SF | Silk fibroin | in situ tissue engineering | In vivo | [71] |
SSF | Silk nanofiber | Tissue engineering/Drug delivery | In vivo | [14] |
SF/PVA | Silk fibroin | Regeneration of nucleus pulposus | In vitro | [57] |
SF/PVA | Silk fibroin | Cartilage tissue engineering | In vivo | [72] |
CANFs@SF/CS | Silk fibroin | Muscle tissue engineering | In vitro | [61] |
AgSrHA@SF/CS | Silk fibroin | Bone tissue engineering | In vivo | [73] |
SF/CS/AR/BG/HA | Silk fibroin | Bone tissue engineering | In vivo | [58] |
laponite@SF | Silk fibroin | Bone tissue engineering | In vivo | [74] |
SF/GS/GM | Silk fibroin | Burn healing | In vivo | [75] |
PDA@SF/CS | Silk fibroin | Healing of full-thickness wounds | In vivo | [60] |
TA/Fe3+@SF/CS | Silk fibroin | Traumatic hemorrhage/Wound healing | In vivo | [59] |
SMC@Ag | Silk sericin | Traumatic hemorrhage/Wound healing | In vivo | [76] |
laminin@Gel/SS | Silk sericin | Cell delivery Healing of diabetic ulcer | In vivo | [77] |
laminin@Gel/SS | Silk sericin | Cell delivery/Cardiac repair | In vivo | [78] |
SF: Silk fibroin; SSF: short silk nanofiber; PVA: Poly (vinyl) alcohol; CANFs: cellulose acetate electrospun nanofibers; AgSrHA: silver and strontium co-doped hydroxyapatite; AR: Agarose; BG: Bioactive glass; HA: Hydroxyapatite; GS: Gentamycin sulfate; GM: Gelatin microspheres; PDA: polydopamine; CS: Chitosan; TA/Fe3+: tannic acid/ferric ion; SMC@Ag: sericin-methacryloyl/silver; Gel: Gelatin; SS: Silk sericin.